Skip to content
Nov 07 2014
Equity Strategies

Biotechnology Now Attractive; Purchased In Select Industries

  • Nov 7, 2014

This group offers low correlation, some defensive qualities, and a dose of volatility. Health Care is now the top rated broad sector and we are overweight this sector in Select Industries Portfolio.

tags

Biotechnology Health Care GS Scores Group Report

Login

For full access, please enter your credentials.

About The Author

Kristen Perleberg / Sr. Research Analyst & Co-Portfolio Manager

Kristen Perleberg Sr. Research Analyst & Co-Portfolio Manager

Kristen is a Senior Analyst and Co-Portfolio Manager of the Grizzly Short Fund.

current issue

November 2020
Volume 40
No 11

featured articles

recent tags
[ALL]

COVID (1) Growth (114) Value (110) Factor Performance (8) Momentum (168) Standard-Deviation (1) FAANG (1) Large Cap Growth (3) Commodities (103) Energy (81) Commodity Stocks (11) GS Scores (304) CPI/PPI Ratio (4) Inflation (529) Emerging Market Stocks (2) Valuations (287) Emerging Markets (84) Emerging Vs. Developed Markets Allocation Strategy (2) Asset Allocation Strategy (7) All Asset No Authority (9)